A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm, transitional cell carcinoma	Recruiting	Phase 1	2026-07-27		NCT07518043

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Henlius Biotech	58

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fujian Medical University Union Hospital	Fuzhou	China	20
The First Affiliated Hospital of Henan University of Science & Technology	Luoyang	China	5
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	26
The First Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	8
The Second Affiliated Hospital of Xi'an Jiaotong University	Xi'an	China	22
The Second Hospital of Tianjin Medical University	Tianjin	China	11
Union Hospital, Tongji Medical College,Huazhong University of Science and Technology	Wuhan	China	2